{"news_desk": "Business", "print_page": null, "section_name": "Business Day", "subsection_name": "DealBook", "byline": {"original": "By PETER EAVIS", "person": [{"rank": 1, "role": "reported", "firstname": "Peter", "organization": "", "lastname": "EAVIS"}]}, "abstract": null, "type_of_material": "News", "word_count": "350", "lead_paragraph": "William Ackman\u2019s hedge fund said in a regulatory filing that its stake was now 8.5 percent, down from 9.9 percent, of the drug company that has been drawing fire on several fronts.", "pub_date": "2016-01-01T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "Ackman Sheds Some Valeant Shares"}, "snippet": "William Ackman\u2019s hedge fund said in a regulatory filing that its stake was now 8.5 percent, down from 9.9 percent, of the drug company that has been drawing fire on several fronts.", "multimedia": [], "web_url": "http://www.nytimes.com/2016/01/01/business/dealbook/ackman-sheds-some-valeant-shares.html", "keywords": [{"rank": "1", "is_major": "N", "value": "Pershing Square Capital Management", "name": "organizations"}, {"rank": "2", "is_major": "N", "value": "Valeant Pharmaceuticals International Inc", "name": "organizations"}, {"rank": "3", "is_major": "N", "value": "Ackman, William A", "name": "persons"}, {"rank": "4", "is_major": "N", "value": "Hedge Funds", "name": "subject"}, {"rank": "5", "is_major": "N", "value": "Drugs (Pharmaceuticals)", "name": "subject"}, {"rank": "6", "is_major": "N", "value": "Pearson, John Michael (1959- )", "name": "persons"}], "blog": [], "_id": "5685d12638f0d85a6c13020b", "source": "The New York Times"}